NYSE:USPH - U.S. Physical Therapy Stock Price, Forecast & News

U.S. Physical Therapy trades on the New York Stock Exchange (NYSE) under the ticker symbol "USPH."

U.S. Physical Therapy announced a quarterly dividend on Thursday, November 7th. Stockholders of record on Monday, November 18th will be given a dividend of $0.30 per share on Friday, December 13th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.00%. The ex-dividend date is Friday, November 15th. View U.S. Physical Therapy's Dividend History.

U.S. Physical Therapy, Inc. (NYSE:USPH) released its quarterly earnings data on Thursday, November, 7th. The company reported $0.71 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.71. The company earned $117.30 million during the quarter, compared to analyst estimates of $121.28 million. U.S. Physical Therapy had a return on equity of 16.57% and a net margin of 6.36%. U.S. Physical Therapy's revenue for the quarter was up 3.7% on a year-over-year basis. During the same quarter last year, the firm earned $0.64 EPS. View U.S. Physical Therapy's Earnings History.

U.S. Physical Therapy is scheduled to release their next quarterly earnings announcement on Thursday, February 27th 2020. View Earnings Estimates for U.S. Physical Therapy.

U.S. Physical Therapy will be holding an earnings conference call on Thursday, February 27th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

U.S. Physical Therapy updated its FY 2019 Pre-Market earnings guidance on Monday, November, 25th. The company provided EPS guidance of $2.80-2.90 for the period, compared to the Thomson Reuters consensus estimate of $2.94.

2 Wall Street analysts have issued 1 year price objectives for U.S. Physical Therapy's shares. Their forecasts range from $106.61 to $130.00. On average, they expect U.S. Physical Therapy's stock price to reach $118.31 in the next twelve months. This suggests that the stock has a possible downside of 1.7%. View Analyst Price Targets for U.S. Physical Therapy.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for U.S. Physical Therapy in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for U.S. Physical Therapy.

News headlines about USPH stock have been trending somewhat positive recently, according to InfoTrie Sentiment. InfoTrie rates the sentiment of news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. U.S. Physical Therapy earned a daily sentiment score of 0.8 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the near term. View News Stories for U.S. Physical Therapy.

U.S. Physical Therapy saw a drop in short interest during the month of December. As of December 31st, there was short interest totalling 994,500 shares, a drop of 7.1% from the December 15th total of 1,070,000 shares. Based on an average daily volume of 101,900 shares, the short-interest ratio is presently 9.8 days. Approximately 7.9% of the shares of the stock are short sold. View U.S. Physical Therapy's Current Options Chain.

Some companies that are related to U.S. Physical Therapy include HCA Healthcare (HCA), Universal Health Services (UHS), Tenet Healthcare (THC), Select Medical (SEM), Acadia Healthcare (ACHC), The Ensign Group (ENSG), Brookdale Senior Living (BKD), National HealthCare (NHC), Hanger (HNGR), Community Health Systems (CYH), Capital Senior Living (CSU), Five Star Senior Living (FVE) and Encompass Health (EHC).

Based on aggregate information from My MarketBeat watchlists, some companies that other U.S. Physical Therapy investors own include Pfizer (PFE), Gilead Sciences (GILD), AbbVie (ABBV), Allergan (AGN), Marathon Petroleum (MPC), UnitedHealth Group (UNH), Cisco Systems (CSCO), PepsiCo (PEP), Starbucks (SBUX) and Walgreens Boots Alliance (WBA).

U.S. Physical Therapy's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Riverbridge Partners LLC (2.92%), Boston Trust Walden Corp (0.94%), Scout Investments Inc. (0.75%), State of Alaska Department of Revenue (0.08%), Louisiana State Employees Retirement System (0.03%) and We Are One Seven LLC (0.02%). Company insiders that own U.S. Physical Therapy stock include Bernard A Harris Jr, Christopher J Reading, Clayton Trier, Edward L Kuntz, Glenn Mcdowell, Graham D Reeve, Harry S Chapman, Jerald L Pullins, Kathleen A Gilmartin, Lawrance W Mcafee, Mark J Brookner and Regg E Swanson. View Institutional Ownership Trends for U.S. Physical Therapy.

USPH stock was sold by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, Scout Investments Inc., AE Wealth Management LLC, Louisiana State Employees Retirement System, State of Alaska Department of Revenue and We Are One Seven LLC. Company insiders that have sold U.S. Physical Therapy company stock in the last year include Christopher J Reading, Clayton Trier, Glenn Mcdowell, Graham D Reeve, Lawrance W Mcafee and Mark J Brookner. View Insider Buying and Selling for U.S. Physical Therapy.

USPH stock was acquired by a variety of institutional investors in the last quarter, including Boston Trust Walden Corp and Squar Milner Financial Services LLC. Company insiders that have bought U.S. Physical Therapy stock in the last two years include Harry S Chapman, Kathleen A Gilmartin and Regg E Swanson. View Insider Buying and Selling for U.S. Physical Therapy.

Shares of USPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of USPH stock can currently be purchased for approximately $120.30.

U.S. Physical Therapy has a market capitalization of $1.54 billion and generates $453.91 million in revenue each year. The company earns $34.87 million in net income (profit) each year or $2.65 on an earnings per share basis. U.S. Physical Therapy employs 4,600 workers across the globe.View Additional Information About U.S. Physical Therapy.

The official website for U.S. Physical Therapy is http://www.usph.com/.

U.S. Physical Therapy's mailing address is 1300 WEST SAM HOUSTON PARKWAY SUITE 300, HOUSTON TX, 77042. The company can be reached via phone at 713-297-7000 or via email at [email protected]